280 related articles for article (PubMed ID: 29556691)
21. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
[TBL] [Abstract][Full Text] [Related]
22. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging for differentiating malignant from benign orbital lymphproliferative disorders.
Xu XQ; Qian W; Hu H; Su GY; Liu H; Shi HB; Wu FY
Acta Radiol; 2019 Feb; 60(2):239-246. PubMed ID: 29804475
[TBL] [Abstract][Full Text] [Related]
23. Differentiating between benign and malignant sinonasal lesions using dynamic contrast-enhanced MRI and intravoxel incoherent motion.
Jiang J; Xiao Z; Tang Z; Zhong Y; Qiang J
Eur J Radiol; 2018 Jan; 98():7-13. PubMed ID: 29279173
[TBL] [Abstract][Full Text] [Related]
24. [The value of dynamic contrast-enhanced MRI in the differentiation between benign and malignant lacrimal epithelial tumors].
Wang YZ; Xian JF; Wang XY; Guo J; Song LY
Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(31):2427-2432. PubMed ID: 37599217
[No Abstract] [Full Text] [Related]
25. Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study.
Thomassin-Naggara I; Balvay D; Aubert E; Daraï E; Rouzier R; Cuenod CA; Bazot M
Eur Radiol; 2012 Apr; 22(4):738-45. PubMed ID: 22105841
[TBL] [Abstract][Full Text] [Related]
26. Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors.
Huang N; Xiao Z; Chen Y; She D; Guo W; Yang X; Chen Q; Cao D; Chen T
Neuroradiology; 2021 Oct; 63(10):1709-1719. PubMed ID: 34241661
[TBL] [Abstract][Full Text] [Related]
27. Dynamic contrast-enhanced MRI versus
Feng F; Qiang F; Shen A; Shi D; Fu A; Li H; Zhang M; Xia G; Cao P
Chin J Cancer Res; 2018 Feb; 30(1):21-30. PubMed ID: 29545716
[TBL] [Abstract][Full Text] [Related]
28. Differentiation between benign and malignant ovarian masses using multiparametric MRI.
Türkoğlu S; Kayan M
Diagn Interv Imaging; 2020 Mar; 101(3):147-155. PubMed ID: 31987805
[TBL] [Abstract][Full Text] [Related]
29. Value of quantitative multiparametric MRI in differentiating pleomorphic adenomas from malignant epithelial tumors in lacrimal gland.
Wang Y; Song L; Guo J; Xian J
Neuroradiology; 2020 Sep; 62(9):1141-1147. PubMed ID: 32430642
[TBL] [Abstract][Full Text] [Related]
30. The value of DCE-MRI in assessing histopathological and molecular biological features in induced rat epithelial ovarian carcinomas.
Yuan SJ; Qiao TK; Qiang JW; Cai SQ; Li RK
J Ovarian Res; 2017 Sep; 10(1):65. PubMed ID: 28950890
[TBL] [Abstract][Full Text] [Related]
31. The clinical value of dynamic contrast-enhanced MRI in differential diagnosis of malignant and benign ovarian lesions.
Li X; Hu JL; Zhu LM; Sun XH; Sheng HQ; Zhai N; Hu XB; Sun CR; Zhao B
Tumour Biol; 2015 Jul; 36(7):5515-22. PubMed ID: 25724182
[TBL] [Abstract][Full Text] [Related]
32. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
Kang SR; Kim HW; Kim HS
J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
[TBL] [Abstract][Full Text] [Related]
34. MR imaging in discriminating between benign and malignant paediatric ovarian masses: a systematic review.
van Nimwegen LWE; Mavinkurve-Groothuis AMC; de Krijger RR; Hulsker CCC; Goverde AJ; Zsiros J; Littooij AS
Eur Radiol; 2020 Feb; 30(2):1166-1181. PubMed ID: 31529256
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of focal indeterminate marrow abnormalities with multiparametric MRI.
Baik JS; Jung JY; Jee WH; Chun CW; Kim SK; Shin SH; Chung YG; Jung CK; Kannengiesser S; Sohn Y
J Magn Reson Imaging; 2017 Jul; 46(1):49-60. PubMed ID: 27859835
[TBL] [Abstract][Full Text] [Related]
36. Apparent diffusion coefficient (ADC) measurement in ovarian tumor: Effect of region-of-interest methods on ADC values and diagnostic ability.
Mukuda N; Fujii S; Inoue C; Fukunaga T; Tanabe Y; Itamochi H; Ogawa T
J Magn Reson Imaging; 2016 Mar; 43(3):720-5. PubMed ID: 26201495
[TBL] [Abstract][Full Text] [Related]
37. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis.
Thomassin-Naggara I; Bazot M; Daraï E; Callard P; Thomassin J; Cuenod CA
Radiology; 2008 Jul; 248(1):148-59. PubMed ID: 18458244
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of preoperative dynamic contrast-enhanced magnetic resonance imaging in epithelial ovarian cancer.
Lindgren A; Anttila M; Arponen O; Rautiainen S; Könönen M; Vanninen R; Sallinen H
Eur J Radiol; 2019 Jun; 115():66-73. PubMed ID: 31084761
[TBL] [Abstract][Full Text] [Related]
39. Radiomics derived from dynamic contrast-enhanced MRI pharmacokinetic protocol features: the value of precision diagnosis ovarian neoplasms.
Song XL; Ren JL; Zhao D; Wang L; Ren H; Niu J
Eur Radiol; 2021 Jan; 31(1):368-378. PubMed ID: 32767049
[TBL] [Abstract][Full Text] [Related]
40. Improved performance in differentiating benign from malignant sinonasal tumors using diffusion-weighted combined with dynamic contrast-enhanced magnetic resonance imaging.
Wang XY; Yan F; Hao H; Wu JX; Chen QH; Xian JF
Chin Med J (Engl); 2015 Mar; 128(5):586-92. PubMed ID: 25698188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
